EUVIMEDEUVIMED entdecken
Crossref

73673 Bimekizumab on-treatment remission as defined by the National Psoriasis Foundation: 1-year results versus ustekinumab and secukinumab in patients with moderate to severe plaque psoriasis

April Armstrong, Lourdes Pérez-Chada, Mark Lebwohl, Deepak M.W. Balak, George M. Lewitt, Richard B. Warren, Richard G. Langley, Diamant Thaçi, George Han, Heather Herr, Andrew Blauvelt

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB82

DOI: 10.1016/j.jaad.2026.04.338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von April Armstrong und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Armstrong, A., Pérez-Chada, L., Lebwohl, M., Balak, D. M., Lewitt, G. M., Warren, R. B., Langley, R. G., Thaçi, D., Han, G., Herr, H., & Blauvelt, A. (2026). 73673 Bimekizumab on-treatment remission as defined by the National Psoriasis Foundation: 1-year results versus ustekinumab and secukinumab in patients with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology, 95(1), AB82. https://doi.org/10.1016/j.jaad.2026.04.338

Vancouver

Armstrong A, Pérez-Chada L, Lebwohl M, Balak DM, Lewitt GM, Warren RB, et al. 73673 Bimekizumab on-treatment remission as defined by the National Psoriasis Foundation: 1-year results versus ustekinumab and secukinumab in patients with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 2026;95(1):AB82. doi:10.1016/j.jaad.2026.04.338

BibTeX
@article{Armstrong2026,
  author = {Armstrong, April and Pérez-Chada, Lourdes and Lebwohl, Mark and Balak, Deepak M.W. and Lewitt, George M. and Warren, Richard B. and Langley, Richard G. and Thaçi, Diamant and Han, George and Herr, Heather and Blauvelt, Andrew},
  title = {73673 Bimekizumab on-treatment remission as defined by the National Psoriasis Foundation: 1-year results versus ustekinumab and secukinumab in patients with moderate to severe plaque psoriasis},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB82},
  doi = {10.1016/j.jaad.2026.04.338}
}
Kostenlos starten →